From: Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review
Type of migraine | Diagnostic criteria |
---|---|
Migraine without aura | At least five attacks that meet the following four criteria: Headache lasting 4–72 h (when untreated or unsuccessfully treated) Headache with at least two of the following four characteristics: unilateral location; Pulsating quality; moderate or severe pain intensity; aggravation by or causing avoidance of routine physical activity (e.g., walking or climbing stairs) Headache accompanied by at least one of the following symptoms: nausea, vomiting, or both; photophobia and phonophobia Not better accounted for by another ICHD-3 diagnosis |
Migraine with aura | At least two attacks that meet the following three criteria: One or more of the following fully reversible aura symptoms: visual; sensory; speech, language, or both; motor; brain stem; retinal At least three of the following six characteristics: at least one aura symptom spreading gradually over a period ≥ 5 min; Two or more aura symptoms occurring in succession; Each aura symptom lasting 5–60 min; at least one unilateral aura symptom; at least one positive aura symptom; headache accompanying the aura or following the aura within 60 min Not better accounted for by another ICHD-3 diagnosis |
Chronic migraine | Headaches (suggestive of migraine or tension headaches) on ≥ 15 days/month for > 3 months that fulfil the following criteria: Occurring in a patient who has had at least five attacks meeting the criteria for migraine without aura or the criteria for migraine with aura or both On ≥ 8 days/month for > 3 months, features of migraine without aura or of migraine with aura or believed by the patient to be migraine at onset that is relieved by a triptan or ergot derivative Not better accounted for by another ICHD-3 diagnosis |